Thursday, May 2, 2024

Book we never heard of ~ Meghan Murphy

 Google is so powerful that it "hides" other search systems from us. We just don't know the existence of most of them.


Meanwhile, there are still a huge number of excellent searchers in the world who specialize in books, science, other smart information.


Keep a list of sites you never heard of.


www.refseek.com - Academic Resource Search. More than a billion sources: encyclopedia, monographies, magazines.


www.worldcat.org - a search for the contents of 20 thousand worldwide libraries. Find out where lies the nearest rare book you need.


https://link.springer.com - access to more than 10 million scientific documents: books, articles, research protocols.


www.bioline.org.br is a library of scientific bioscience journals published in developing countries.


http://repec.org - volunteers from 102 countries have collected almost 4 million publications on economics and related science.


www.science.gov is an American state search engine on 2200+ scientific sites. More than 200 million articles are indexed.


www.base-search.net is one of the most powerful researches on academic studies texts. More than 100 million scientific documents, 70% of them are free

Turbo Cancer ~ Brian Mitchell

 Turbo Cancers - Part One 


Pfizer 'Chose not to' Tell regulators about SV40 sequence in the jabs


April 23rd, 2024

The Epoch Times Archived To Bypass Paywall

https://archive.fo/41OvU

-----------

6 new COVID-19 Vaccine Turbo Cancer papers published in April 2024 - 26 total 


https://makismd.substack.com/p/turbo-cancer-literature-is-growing


TURBO CANCER LITERATURE (15 papers/preprints):


(2024 Apr, Zhang and El-Deiry) - SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells

https://www.biorxiv.org/content/10.1101/2024.04.12.589252v1


(2024 Apr, Rubio-Casillas et al) - Review: N1-methyl-pseudouridine

https://pubmed.ncbi.nlm.nih.gov/38583833/


(2024 Apr, Gibo et al) - Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/


(2023 Dec, Angues et al) - SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis

https://pubmed.ncbi.nlm.nih.gov/38234925/


(2023 Nov, Patrick Chambers) - The CD147 Epitope on SARS CoV2 and the Spike in Cancer, Autoimmunity and Organ Fibrosis

https://www.researchgate.net/publication/375312458_The_CD147_Epitope_on_SARS_CoV2_and_the_Spike_in_Cancer_Autoimmunity_and_Organ_Fibrosis


(2023 Oct, Speicher et al) - DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.

https://osf.io/xv3nz/


(2023 Sep, McKernan et al) - Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose

https://www.researchgate.net/publication/369967228_Sequencing_of_bivalent_Moderna_and_Pfizer_mRNA_vaccines_reveals_nanogram_to_microgram_quantities_of_expression_vector_dsDNA_per_dose


(2023 May, Uversky, Redwan, Makis, Rubio-Casillas) - IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

https://pubmed.ncbi.nlm.nih.gov/37243095/


(2023 May, Eens et al) - B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/


(2023 Apr, Halma, Rose, Lawrie) - The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

https://www.mdpi.com/2571-8800/6/2/17


(2023 March, Guetzkow et al) - National Academies Committee on Review of Relevant Literature Regarding Adverse Events Associated with Vaccines

https://nationalcitizensinquiry.b-cdn.net/wp-content/uploads/2023/09/VT-3tt-Makis-Wiseman-06b-Turbo-Cancer-Paper16-Wiseman.pdf


(2022 Apr, Seneff et al) - Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs

https://pubmed.ncbi.nlm.nih.gov/35436552/


(2022 Feb, Alden et al) - Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

https://pubmed.ncbi.nlm.nih.gov/35723296/


(2020 Oct, Singh) - S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study

https://pubmed.ncbi.nlm.nih.gov/32619819/


(2024 Apr, Abdurrahman et al) - Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

https://pubmed.ncbi.nlm.nih.gov/38608126/


(2024 Apr, Ueda et al) - Fetal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case

https://pubmed.ncbi.nlm.nih.gov/38619098/


(2024 Apr, Gentilini et al) - A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature

https://www.scienceopen.com/document?vid=90c33e63-5123-4b10-8af1-dfa006d84909


(2023 Sep, Kyriakopoulos et al) - Bell’s palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature

https://pubmed.ncbi.nlm.nih.gov/37927346/


(2023 Apr, Tachita et al) - Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination

https://pubmed.ncbi.nlm.nih.gov/37093551/


(2023 Jan, Cavanna et al) - Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature

https://pubmed.ncbi.nlm.nih.gov/36676781/


(2022 Sep, Revenga-Porcel et al) - 76M lymphoma after 3rd Moderna mRNA

https://onlinelibrary.wiley.com/doi/10.1111/jdv.18615


(2022 Aug, Sekizawa et al) - 80F lymphoma after 2nd Pfizer mRNA

https://pubmed.ncbi.nlm.nih.gov/35979213/


(2022 Jun, Zamfir et al) - 58F 2nd Pfizer, 53M 2nd Pfizer both lymphoma

https://pubmed.ncbi.nlm.nih.gov/35888593/


(2022 Apr, Mitsui et al) - 67M 2nd Pfizer, 80F 2nd Pfizer both lymphoma

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114986/


(2021 Nov, Goldman et al) - 66M lymphoma progression after 3rd Pfizer mRNA

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656165/


Four members of Glasgow family diagnosed with cancer:

https://www.glasgowtimes.co.uk/news/20584938.our-family-much-four-members-glasgow-family-diagnosed-cancer/


Chief Pathologist Lunds University, Sweden...seeing aggressive tumors in younger patients, sometimes in both breasts...

https://etana.substack.com/p/turbo-cancer

-----------

Plasmids

https://www.facebook.com/kathi.roussel/posts/pfbid0x2aJvopxYoMPafqRFDNAWJrabgK19cEdLjGj9XQejSt3pEdoY5AokQ8Xus2ybHMol

------------

SV40 Explainer & Video....

Plasmids 101

Are you interested in learning what a SV40 promoter does?

{ Think "cancer"... }

https://www.facebook.com/brian.mitchell.3158/posts/pfbid021NhUTozSMqH8hXMzY7w16HsKqiYwqJNQ9U2y1VycBULTmavWYchS6FUojQVnjoD9l